Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Cryostat Offers High-Quality, Efficient Frozen Sectioning

Published: Monday, December 23, 2013
Last Updated: Sunday, December 22, 2013
Bookmark and Share
Improved ergonomics and functionality improve operator comfort and enhance workflow.

A new manual cryostat offers scientists improved functionality and ergonomics, ensuring efficient high quality frozen sectioning.

Sectioning temperature is critical in generating a good quality fresh frozen tissue section. The Thermo Scientific Cryostar NX50 is an innovative cryostat incorporating knife cooling and adjustable specimen head temperature for rapid adjustment to meet the temperature requirements for each specimen.

“Pathologists rely on quick turnaround time and excellent sectioning quality from their cryostat,” said Richard Vernon, Commercial Product Manager, Thermo Fisher Scientific. “Our Cryostar NX50 gives them the functionality and control to achieve diagnosis rapidly.”

Designed with an LCD touch screen interface operation is streamlined for the user. By utilizing icon driven software parameters can be changed simply and quickly to meet the demands of different specimen types.

In addition, the Cryostar NX50 offers:

• Optional motorized height adjustment, allowing the operator to customize the position of the cryochamber for either seated or standing operation.
• Optional Cold D disinfection system for rapid, on demand decontamination of the cryochamber, protecting the operator from exposure to biological pathogens with minimal downtime.
• Optional, variable-pressure vacutome, which delivers wrinkle-free sections by gently stretching the specimen during cutting.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Completes Sale of Cole-Parmer to GTCR
Thermo Fisher Scientific Inc. announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for approximately $480 million in cash.
Wednesday, August 20, 2014
Thermo to Sell Cole-Parmer for $480M
Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.
Monday, July 21, 2014
Thermo Completes Sale of Certain Assets to GE
Thermo has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare for $1.065 billion.
Monday, March 24, 2014
Thermo Completes Life Tech Acquisition
The completion of the transaction follows the receipt of all required regulatory approvals.
Tuesday, February 04, 2014
Thermo Scientific North Carolina Site Wins IndustryWeek’s Best Plant Award
Center of Excellence honored for exceptional performance, safety and processes.
Wednesday, January 15, 2014
Thermo Receives EC Clearance for Life Tech Acquisition
Thermo Fisher Scientific announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation.
Tuesday, November 26, 2013
Blood Banks Provide Vital Resource in Global Blood Supply Chain
Thermo Fisher installs 1000th blood banking centrifuge in India.
Monday, November 18, 2013
Thermo Scientific Offering to be Highlighted at ISSCR Stem Cell Research Symposium
The symposium highlights the latest Thermo Scientific tools and technologies available to researchers to advance their understanding of stem cells.
Tuesday, July 07, 2009
Thermo Fisher Scientific Sponsors Shanghai Conference on Stem Cell Research
Thermo Scientific sponsors the 2009 Shanghai Symposium of Stem Cell Research and Regenerative Medicine at the Shanghai Tong Ji University.
Thursday, May 14, 2009
Thermo Fisher Scientific to Highlight new Cell-based Technologies at ASCB 2008
The Company will showcase the latest tools and methods related to key mammalian cell-based research.
Friday, December 12, 2008
Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research
Symposium program will unveil new methods and technologies for stem cell scientists.
Tuesday, June 10, 2008
Thermo Fisher Scientific Launches New Cell Culture Excellence Program
The program is designed to provide essential products and services to address the daily challenges associated with culturing mammalian cells.
Tuesday, June 03, 2008
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!